# The Effect of Nebivolol in Hypertensive Patients With Coronary Arterial Spasm

> **NCT03930433** · PHASE4 · COMPLETED · sponsor: **Korea University Anam Hospital** · enrollment: 51 (actual)

## Conditions studied

- Coronary Vasospasm

## Interventions

- **DRUG:** Nebivolol
- **DRUG:** Diltiazem
- **DRUG:** Nebivolol+Diltiazem

## Key facts

- **NCT ID:** NCT03930433
- **Lead sponsor:** Korea University Anam Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-01
- **Primary completion:** 2019-03-31
- **Final completion:** 2019-03-31
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2020-03-10

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03930433

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03930433, "The Effect of Nebivolol in Hypertensive Patients With Coronary Arterial Spasm". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT03930433. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*